What You Should Know:
– Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of…
Continue Reading
Dale Greenwood, NHS clinical and strategic programme lead for North East London Mental Health Support Teams
Evidence-based digital support is essential to meet the demand on children and young people’s mental health services, writes…
Continue Reading
Steve Blunden, Peninsula Pathology digital pathology lead (first on right), alongside Peninsula Pathology Network and University Hospitals Plymouth NHS Trust teams (Credit: University Hospitals Plymouth NHS Trust)
Five NHS sites in Devon and Cornwall…
Continue Reading
Brett Talbot, Ph.D., co-founder and CCO of Videra Health
The progression of artificial intelligence in healthcare has largely occurred in silos, with innovations developing within specific medical domains rather than across them. Yet some of…
Continue Reading
Kevin Coady, Business Leader for Disease Management Solutions & Digital Pathology at Philips North America
Understanding Prostate Cancer: Not All Are the Same
Prostate cancer is the second most common cancer in men, but what many…
Continue Reading
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful, disfiguring, inflammatory lesions such as nodules, abscesses and fistulas in intertriginous sites. It significantly impacts patients’ quality of life. Early diagnosis…
Continue Reading
(L to R) Dr Yola Jones of Seluna, Dr Ruth Hamilton, Dr Scott Black of Seluna, Prof Haytham Kubba, and Innes Taylor of Seluna (Credit: Martin Shields Photography)
Glasgow-based MedTech firm Seluna has launched…
Continue Reading
Image credit: Icahn School of Medicine at Mount Sinai
What You Should Know:
– Researchers at the Icahn School of Medicine at Mount Sinai have developed a new method using artificial intelligence (AI) and routine lab…
Continue Reading
Nurses across England will be trained as ‘genomics champions’ to help patients get faster diagnoses and access treatment closer to home, as the part of the government’s 10 year health plan.
The government is creating…
Identification of cohorts at higher risk of cancer can enable earlier diagnosis of the disease, which significantly improves patient outcomes. In this study, we select nine cancer sites with high incidence of late-stage diagnosis…
Continue Reading
